## HON: Honeywell International Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.5% below STRENGTH zone (3.0-6.0%); PEG 1.83 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($183.59)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. State Street Corp Reduces Stock Holdings in Honeywell International Inc. $HON**
- Source: MarketBeat | 20251209T140809 | Neutral | Relevance: 99%
- State Street Corp significantly reduced its stake in Honeywell International Inc. ($HON) by 0.1% in the second quarter, now owning 30,901,360 shares worth over $7.19 billion. Despite this reduction, other institutional investors like Wellington Management Group LLP and Bank of New York Mellon Corp increased their holdings. Wall Street analysts have a "Hold" consensus rating for Honeywell, with a target price of $236.65, and the company recently reported strong quarterly earnings and increased its dividend.

**2. Jump Financial LLC Boosts Position in Honeywell International Inc. $HON**
- Source: MarketBeat | 20251207T114322 | Somewhat-Bullish | Relevance: 99%
-  Jump Financial LLC significantly increased its stake in Honeywell International Inc. (NASDAQ:HON) during the second quarter, raising its position by 5,981.6% to own 133,796 shares valued at approximately $31.16 million. Despite a consensus "Hold" rating from Wall Street analysts and recent price target trims by several firms, Honeywell reported strong quarterly EPS and revenue, setting optimistic guidance for Q4 and the full fiscal year, and also increased its quarterly dividend. Other institutional investors also adjusted their holdings in Honeywell, which currently has a market cap of $121.47 billion.

**3. Fayez Sarofim & Co Has $6.79 Million Holdings in Honeywell International Inc. $HON**
- Source: MarketBeat | 20251209T110849 | Somewhat-Bullish | Relevance: 99%
-  Fayez Sarofim & Co significantly increased its stake in Honeywell International Inc. by 35.5% during the second quarter, now holding 29,164 shares valued at approximately $6.79 million. Honeywell recently reported strong quarterly earnings of $2.25 EPS on $8.95 billion revenue, provided positive Q4 and FY2023 guidance, and raised its quarterly dividend to $1.19 per share. Analysts generally rate HON as a "Hold" with a consensus price target of $236.65, despite recent price objective reductions from several firms.

**4. Insiders At Honeywell International Sold US$1.5m In Stock, Alluding To Potential Weakness**
- Source: Yahoo Finance | 20251208T060000 | Neutral | Relevance: 99%
-  Over the past year, Honeywell International insiders have sold US$1.5 million worth of stock, raising questions for shareholders. While insider selling can send mixed signals, the volume of sales by multiple insiders suggests further investigation is warranted. The largest individual sale was by Lucian Boldea, who offloaded US$1.3 million in shares at US$221 each, a price higher than the current market value.

**5. Deutsche Bank Adjusts Honeywell International PT to $264 From $265, Maintains Buy Rating**
- Source: marketscreener.com | 20251208T134318 | Neutral | Relevance: 98%
-  Deutsche Bank has adjusted its price target for Honeywell International (HON) to $264, a slight reduction from the previous $265. Despite this minor change, the bank has chosen to maintain its "Buy" rating for the company. This update reflects Deutsche Bank's continued positive outlook on Honeywell's stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Barclays | $269 | $270 | -0% |
| 2025-11-18 | B of A Securiti | $205 | $265 | -23% |
| 2025-11-10 | TD Cowen | $240 | $250 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Barclays | main | Overweight |
| 2025-11-18 | B of A Securiti | down | Underperform |
| 2025-11-10 | TD Cowen | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($0.12M) |
| Sells | 5 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (-0.3%)
- Blackrock Inc.: 7.1% (+6.1%)
- State Street Corpora: 4.4% (-0.8%)
- JPMORGAN CHASE & CO: 3.0% (+112.5%)
- Morgan Stanley: 2.7% (+0.1%)

### Key Risks

1. Long-term trend broken: trading 6.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.83 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 35%, margin 15%). Balance sheet: $2.9B free cash flow. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $128.1B |
| Beta | 0.95 |
| 52W Range | $169.05 - $227.82 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.83 |
| Forward P/E | 18.0 |
| Current P/E | 17.9 |
| YoY Growth | -0.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.7% over 5 days). Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.50% (CS: 43) | Neutral |
| RSI_14 | 42.8 | Neutral |
| MACD Histogram | 0.09 | Bullish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 0.973x | Below |
| vs SMA200 | 0.940x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $190.17
- **Stop Loss:** $183.59 (3.5% risk)
- **Target:** $196.75 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $14,262.75
- **Portfolio %:** 14.26%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-05 (Est: $2.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.57 | $2.82 | +9.9% |
| 2025Q2 | $2.66 | $2.75 | +3.4% |
| 2025Q1 | $2.21 | $2.51 | +13.6% |
| 2024Q4 | $2.35 | $2.47 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*